Skip to search formSkip to main contentSkip to account menu

Histone-Lysine N-Methyltransferase EZH2 Inhibitor GSK2816126

Known as: EZH2 Inhibitor GSK2816126, GSK2816126 
A small molecule selective and S-adenosyl methionine (SAM) competitive inhibitor of histone-lysine N-methyltransferase EZH2, with potential… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Abstract EZH2 gain of function mutations (EZH2GOFmu) has been implicated in the pathogenesis of B-non-Hodgkin lymphoma. The EZH2… 
2020
2020
Patients with distant metastasis at the time of diagnosis have significantly worse prognosis. Triple negative breast carcinomas… 
2017
2017
rubicin, epirubicin, vinblastine, etoposide, paclitaxel, and topotecan. RTI‐79's PK characteristics are similar to rifabutin and… 
2016
2016
Background: Triple negative (estrogen receptor, progesterone receptor, HER2-neu negative) breast cancers (TNBC) comprise 15% of… 
2016
2016
  • 2016
  • Corpus ID: 207760052
coimmunoprecipitates, they observed an association of both proteins. Pharmacologic inhibition of the JAK/STAT5 signaling pathway… 
2014
2014
Germinativni centri (GC) folikula sekundarnog limfnog tkiva iznimno su dinamican okolis gdje B‐limfociti prolaze klonalnu… 
2013
2013
Introduction We investigate the role of Ezh2 in neutrophil function using murine progenitor cells differentiated into neutrophils… 
2010
2010
Breast cancer is a very common cancer around the world and overexpression of HER2 is found in 20-25% of the patients. HER2 is a… 
2007
2007
Purpose: PR (PRDI-BF1and RIZ) domain proteins (PRDM) are a subfamily of the kruppel-like zinc finger gene products that play key…